Through genetic and cellular studies, we demonstrated that nutrition repletion inactivates AMPK-TBC1D1 signaling, augments the level of GTP-bound Rab2A, and then increases the protein stability of PPARγ and the expression of PPARγ target genes, and ultimately contributes to the development of NAFLD. This evidence concerns the gene PPARG and metabolic dysfunction-associated steatotic liver disease.